A perspective on modelling hepatitis C virus infection
Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C
Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C
Hepatitis C virus infection diagnosis using metabonomics
Association between phospholipids and free cholesterol in high-density lipoprotein and the response to hepatitis C treatment in Japanese with genotype 1b
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes
Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination
Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996–2007 †
Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis
Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection